诚达药业：前海晟泰拟减持公司不超7.11%股份

Group 1 - The core point of the article is that Chengda Pharmaceutical (301201) announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) plans to reduce its stake by up to 11,006,900 shares, which represents 7.11% of the company's total share capital, within three months after 15 trading days [1] Group 2 - The reduction will be executed through centralized bidding or block trading methods [1] - The announcement was made on the evening of September 5 [1] - The shareholder currently holds a 7.11% stake in the company [1]